Factor-XIIIa-positive dendrocytes in drug-induced toxic epidermal necrolysis (Lyell's syndrome): paradoxical activation in skin and rarefaction in lymph nodes.
[en] BACKGROUND: Drug-induced toxic epidermal necrolysis (TEN) is a rare life-threatening disease characterized by the extensive destruction of the epidermis contrasting with the discreteness of lymphoid cell infiltration. The precise pathomechanism of the disease remains unclear. METHODS: Skin specimens and peripheral and thoracic lymph nodes (LNs) were collected from 2 TEN patients. They were examined by conventional histology and immunohistochemistry using antibodies directed to factor XIIIa (dermal dendrocytes), CD1a (Langerhans cells), CD15 (granulocytes), CD20 (B lymphocytes), CD45RO (activated T lymphocytes), CD68 (macrophages) and the proliferation marker Ki-67. LNs from patients with mycosis fungoides, from subjects dead from acute cardiac failure or traumatic injuries, as well as metastasis-free sentinel LNs of cutaneous melanoma served as positive and negative controls. RESULTS: TEN LNs showed absence of germinal centers but a moderate hyperplasia of the paracortical T cell zone. Immunohistochemistry did not reveal any distinctive aspect in LN cellular densities between TEN and other control conditions except for the factor-XIIIa+ dendritic cells which were dramatically reduced in numbers in TEN LNs. This rarefaction in LNs contrasted with the great number of these cells in the skin of the same patients. CONCLUSION: The structure of TEN LNs rules out the involvement of an antibody-mediated response. As dendritic factor-XIIIa+ cells are involved in most cutaneous T-cell-mediated responses, their depletion in TEN LNs could explain the sparse lymphoid cell infiltrate in lesional TEN skin.
Disciplines :
Dermatology
Author, co-author :
Paquet, Philippe ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie
Quatresooz, Pascale ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie
Pierard, Gérald ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie
Language :
English
Title :
Factor-XIIIa-positive dendrocytes in drug-induced toxic epidermal necrolysis (Lyell's syndrome): paradoxical activation in skin and rarefaction in lymph nodes.
Fritsch, F.O., Sidoroff, A., Drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis (2000) Am J Clin Dermatol, 1, pp. 349-360
Inamo, Y., Okubo, T., Wada, M., Fuchigami, S., Hashimoto, K., Fuchigami, T., Takahashi, S., Harada, K., Intravenous ulinastatin therapy for Stevens-Johnson syndrome and toxic epidermal necrolysis in pediatric patients (2002) Int Arch Allergy Immunol, 127, pp. 89-94
Paquet, P., Piérard, G.E., Erythema multiforme and toxic epidermal necrolysis: A comparative study (1997) Am J Dermatopathol, 19, pp. 127-132
Thivolet, J., Beguin, A.J., André, D., Anticorps 'pemphigus-like' et 'pemphigoid-like' (1970) Dermatologica, 140, pp. 310-317
Van Joost, T.H., Incidence of circulating antibodies reactive with basal cells of skin in drug reactions (1974) Acta Derm Venereol, 54, pp. 183-187
Hensen, E.J., Claas, F.H.J., Vermeer, B.J., Drug-dependent binding of circulating antibodies in drug induced toxic epidermal necrolysis (1981) Lancet, 2, pp. 151-152
King, T., Helm, T.N., Valenzuela, R., Bergfeld, W., Diffuse intraepidermal deposition of immunoreactants on direct immunofluorescence: A clue to the early diagnosis of epidermal necrolysis (1994) Int J Dermatol, 33, pp. 634-636
Paquet, P., Piérard, G.E., Would cyclosporin A be beneficial to mitigate drug-induced toxic epidermal necrolysis? (1999) Dermatology, 198, pp. 198-202
Paquet, P., Paquet, F., Al Saleh, W., Reper, P., Vanderkelen, A., Piérard, G.E., Immunoregulatory effector cells in drug-induced toxic epidermal necrolysis (2000) Am J Dermatopathol, 22, pp. 413-417
Correia, O., Delgado, L., Ramos, J.P., Resena, C., Fleming-Torrinha, J.A., Cutaneous T cell recruitment in toxic epidermal necrolysis: Further evidence of CD8+ lymphocyte involvement (1993) Arch Dermatol, 129, pp. 466-468
Correia, O., Delgado, L., Barbosa, I.L., Domingues, J.C., Azevedo, R., Vaz, C.P., Pimentel, P., CD8+ lymphocytes in the blister fluid of severe acute cutaneous graft versus host disease: Further similarities with toxic epidermal necrolysis (2001) Dermatology, 203, pp. 212-216
Paquet, P., Piérard, G.E., Epidermal calprotectin in drug-induced toxic epidermal necrolysis (1999) J Cutan Pathol, 26, pp. 301-305
Paquet, P., Piérard, G.E., Keratinocyte injury in drug-induced toxic epidermal necrolysis: Simultaneous but distinct topographic expression of CD95R and calprotectin (2002) Int J Mol Med, 10, pp. 145-147
Headington, J.T., Cerio, R., Dendritic cells and the dermis: 1990 (1990) Am J Dermatopathol, 12, pp. 217-220
Nestle, F.O., Turka, L.A., Nickoloff, B.J., Characterization of dermal dendritic cells in psoriasis. Auto-stimulation of T lymphocytes and induction of Th1 type cytokines (1994) J Clin Invest, 94, pp. 202-209
Roujeau, J.C., Stern, R.S., Severe adverse cutaneous reactions to drugs (1994) N Engl J Med, 331, pp. 1272-1285
Paquet, P., Nikkels, A., Arrese, J.E., Vanderkelen, A., Piérard, G.E., Macrophages and tumor necrosis factor α in toxic epidermal necrolysis (1994) Arch Dermatol, 130, pp. 605-608
Kosco-Vilbois, M., Bonnefoy, J.Y., Chvatchko, Y., The physiology of murine germinal center reactions (1997) Immunol Rev, 156, pp. 127-136
Nestle, F.O., Filgueira, L., Nickoloff, B.J., Burg, G., Human dermal dendritic cells process and present soluble protein antigens (1998) J Invest Dermatol, 110, pp. 762-766
Robert, C., Fuhlbridgge, R., Kieffer, D., Ayehunic, S., Hynes, R.O., Cheng, G., Grabbe, S., Kupper, T.S., Interaction of dendritic cells with skin endothelium: A new perspective in immunosurveillance (1999) J Exp Med, 189, pp. 627-635
Cerio, R., Griffiths, C.E.M., Cooper, K.D., Nickoloff, B.J., Headington, J.F., Characterization of factor XIIIa-positive dermal dendritic cells in normal and inflamed skin (1989) Br J Dermatol, 14, pp. 421-431
Kurts, C., Cannarile, M., Klebba, I., Brocker, T., Cutting edge: Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo (2001) J Immunol, 166, pp. 1439-1442
Hermanns-Lê, T., Paquet, P., Piérard-Franchimont, C., Arrese, J.E., Piérard, G.E., Regulatory function of factor-XIIIa-positive dendrocytes in incipient toxic epidermal necrolysis and graft-versus-host reactions (1999) Dermatology, 198, pp. 184-186
Nemes, Z., Adany, R., Thomazy, V., Selective visualization of human dendritic reticulum cells in reactive lymphoid follicles by the immunohistochemical demonstration of the subunit A of factor XIII (F-XIIIa) (1987) Virchows Arch (Cell Pathol), 52, pp. 453-466
Adany, R., Szegedi, A., Ablin, R., Muszbek, L., Fibrinolysis resistant fibrin deposits in lymph nodes with Hodgkin's disease (1988) Thromb Haemost, 60, pp. 193-197
Sallusto, F., Lanzavecchia, A., Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression (2000) Immunol Rev, 177, pp. 134-140
Robert, C., Kupper, T.S., Inflammatory skin diseases, T cells, and immune surveillance (1999) N Engl J Med, 341, pp. 1817-1828
Sallusto, F., Schaerli, P., Loetscher, P., Schaniel, C., Lenig, P., Mackay, C.R., Qin, S., Lanzavecchia, A., Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation (1998) Eur J Immunol, 28, pp. 2760-2769
Vermaelen, K.Y., Carro-Micino, I., Lambrecht, B.N., Pauwels, R.A., Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes (2001) J Exp Med, 193, pp. 51-60
Haig, D.M., Hopkins, J., Miller, H.R.P., Local immune responses in afferent and efferent lymph (1999) Immunology, 96, pp. 155-163
Dieu, M.C., Vanbervliet, B., Vicari, A., Bridon, J.M., Oldham, E., Ait-Yakica, S., Brière, F., Caux, C., Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites (1998) J Exp Med, 188, pp. 373-386
Cyster, J.G., Chemokines and the homing of dendritic cells to the T cell areas of lymphoid organs (1999) J Exp Med, 189, pp. 447-450
